Remdesivir for Outpatient Management: Time to  Wait, Not to Act

In their Commentary, Mardikar et al1 describe their case conducted within one hospital where only 15 moderate risk patients with oxygen saturation ≥ 94% required neither actual hospitalisation nor remdesivir. None of the guidelines across the globe recommend remdesivir for patients having saturation ≥ 94% who can stay at home. The Infectious Diseases Society of America (ISDA) guidelines recommended the use of remdesivir only for hospitaliz ed patients with severe COVID-19 (which is defined as patients with SpO2 ≤ 94% on room air, or those who require supplemental oxygen).
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Letter Source Type: research